People

Bennett-Allen
Bennett Allen, PhD
NYU Langone Health - Assistant Professor
Education
PhD, Epidemiology, NYU Grossman School of Medicine
MPA, Public Policy, New York University
BA, Comparative Literature, New York University
Research Interests
Overdose, drug policy, policing, public health ethics, social determinants of health, harm reduction
BIO
Bennett Allen is an Assistant Professor at the Center for Opioid Epidemiology and Policy, Department of Population Health. His research uses epidemiologic, econometric, and machine learning methods to evaluate supply-side strategies to reduce overdose death. Additional work engages bioethics in relation to public health policy. Current projects examine the impact of drug-induced homicide laws and prosecutions on opioid overdose mortality, the role of prescription drug monitoring programs in pain management cessation, spatiotemporal prediction of overdose mortality risk, and the ethical uses of big data in public health practice. Prior to joining NYU, he worked in drug policy for the New York City government.
Projects
Principal Investigator, Big Data and the Opioid Overdose Epidemic: Algorithmic Ethics and Public Health Practice. Completed
Publications

Recent

Allen B, Basaraba C, Corbeil T, Rivera BD, Levin FR, Martinez DM, Schultebraucks K, Henry BF, Pincus HA, Arout C, Krawczyk N (2023).
Racial differences in COVID-19 severity associated with history of substance use disorders and overdose: Findings from multi-site electronic health records in New York City
Preventive Medicine, 172, 107533. doi: 10.1016/j.ypmed.2023.107533. PMCID: PMC10155467.

Cartus AR, Goedel WC, Jent VA, Macmadu A, Pratty C, Hallowell BD, Allen B, Li Y, Cerda M, Marshall BDL (2023).
Neighborhood-level association between release from incarceration and fatal overdose, Rhode Island, 2016-2020
Drug and Alcohol Dependence, 247, 109867. doi: 10.1016/j.drugalcdep.2023.109867.

Allen B, Urmanche A (2023).
NYC RxStat: Stakeholder perspectives on a national model public health and public safety partnership to reduce overdose deaths
Evaluation and Program Planning, 98, 102275. doi: 10.1016/j.evalprogplan.2023.102275.

Allen B, Neill DB, Schell RC, Ahern J, Hallowell BD, Krieger M, Jent VA, Goedel WC, Cartus AR, Yedinak JL, Pratty C, Marshall BDL, Cerda M (2023).
Translating predictive analytics for public health practice: A case study of overdose prevention in Rhode Island
American Journal of Epidemiology [Epub 2023 May 17]. doi: 10.1093/aje/kwad119.

Krawczyk N, Rivera BD, Basaraba C, Corbeil T, Allen B, Schultebraucks K, Henry BF, Pincus HA, Levin FR, Martinez D (2023).
COVID-19 complications among patients with opioid use disorder: A retrospective cohort study across five major NYC hospital systems
Addiction, 118 (5), 857-869. doi: 10.1111/add.16105. PMCID: PMC9878119.


Notable

Allen B, Harocopos A, Chernick R (2020).
Substance use stigma, primary care, and the New York State prescription drug monitoring program
Behavioral Medicine, 46 (1), 52-62. doi: 10.1080/08964289.2018.1555129.

Dr. Allen's Google Scholar Profile